Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00211549 · ClinicalTrials.gov registry record · Phase 2
An Effectiveness and Safety Study of IDEA-033 in Comparison to Oral Naproxen and Placebo for the Treatment of Osteoarthritis of the Knee
A Phase 2 study of Osteoarthritis, Knee, sponsored by IDEA.
- Completed
- Registry status
- Phase 2
- Development phase
- 875
- Enrollment target
- 20
- Study locations
NCT00211549 is a Phase 2 study of Osteoarthritis, Knee that has completed, run by IDEA. The registered enrollment target is 875 participants, above the 570-participant average among 91 other Osteoarthritis, Knee trials with a reported enrollment target (54% higher). The trial reports 20 study locations across 5 states.
The verdict
NCT00211549, a Phase 2 study of Osteoarthritis, Knee, has completed, sponsored by IDEA.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 875 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to identify the dose(s) of IDEA-033 that will provide a meaningful effect for treating osteoarthritis of the knee.
Conditions Studied
Interventions
- DRUG IDEA-033
Study Locations (20)
California
- - Anaheim
- - Encinitas
- - Fair Oaks
- - Garden Grove
- - Irvine
- - Paramount
- - Rancho Mirage
- - San Diego
- - Spring Valley
- - Temecula
- - Vista
Alabama
- - Birmingham
- - Montgomery
- Drug Research and Analysis Corporation - Montgomery
- - Northport
Arizona
- - Mesa
- - Phoenix
- - Tempe
Colorado
- - Northglenn
Connecticut
- - Danbury
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 875 participants |
| Start Date | 2005-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00211549
The ClinicalTrials.gov registry entry for NCT00211549 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 875 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 570-participant average among 91 other Osteoarthritis, Knee trials with a reported enrollment target (54% higher). The listed sponsor is IDEA, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Osteoarthritis, Knee appearing as the primary indexed condition, and to 1 intervention - of which IDEA-033 is the first listed.
NCT00211549 reports 20 study locations spanning 5 distinct geographic areas - top geographies include California, Alabama, Arizona.
Frequently Asked Questions
What is clinical trial NCT00211549 about?
NCT00211549 is a clinical study titled "An Effectiveness and Safety Study of IDEA-033 in Comparison to Oral Naproxen and Placebo for the Treatment of Osteoarthritis of the Knee". The purpose of this study is to identify the dose(s) of IDEA-033 that will provide a meaningful effect for treating osteoarthritis of the knee.
What is the current status of trial NCT00211549?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 875 participants. The study started on 2005-06.
What conditions does trial NCT00211549 study?
This clinical trial studies the following conditions: Osteoarthritis, Knee.
What interventions are being tested in trial NCT00211549?
The interventions under investigation include: IDEA-033 (DRUG).
Who is sponsoring clinical trial NCT00211549?
This trial is sponsored by IDEA, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00211549 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis, Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Preventing Injured Knees From osteoArthritis: Severity Outcomes
RECRUITING · Phase 2
-
Generate and Test the Reliability of a PD Model of OXT on Pupillary Hippus as a Measure of CNS Activity
RECRUITING · Phase 2
-
Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee
RECRUITING · Phase 2
-
Cannabidiol for Postoperative Opioid Reduction in Primary Total Knee Arthroplasty
RECRUITING · Phase 2
-
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
RECRUITING · Phase 2
-
A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee Osteoarthritis
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.